Stock ARDS ARIDIS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Aridis Pharmaceuticals, Inc.

Equities

ARDS

US0403341045

Delayed OTC Markets
Other stock markets
 02:07:52 2024-04-26 pm EDT 		5-day change 1st Jan Change
0.065 USD 0.00% Intraday chart for Aridis Pharmaceuticals, Inc. +8.33% -7.28%
2023 Aridis Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
2023 Certain Options of Aridis Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 16-SEP-2023. CI

Chart calendar Aridis Pharmaceuticals, Inc.

e.gJ3ZpuRUmST5ildqxIlhBNguFkKsArKk1C0wv_kRZJs.4_G7noYnqF7PxhRS8bgIUbdNIi3EVseRmWVK8Y19MuLq643hgxr9T4n4bw~32dbfd91b284d0b4814d954eb1265b0d

Upcoming events on Aridis Pharmaceuticals, Inc.

2024-05-13 Q1 2024 Earnings Release (Projected)
2024-08-12 Q2 2024 Earnings Release (Projected)
2024-11-19 Q3 2024 Earnings Release (Projected)
2025-05-19 Q1 2025 Earnings Release (Projected)

Past events on Aridis Pharmaceuticals, Inc.

2024-01-12 12:00 pm Annual General Meeting
2023-12-15 12:00 pm Annual General Meeting
2023-11-03 04:15 pm Q3 2023 Earnings Release
2023-06-08 04:05 pm Q1 2023 Earnings Release
2023-01-25 04:15 pm Aridis Pharmaceuticals Corporate Update Conference Call
2022-11-21 06:30 pm Q3 2022 Earnings Release
2022-08-16 04:15 pm Interim 2022 Earnings Release
2022-06-07 11:00 am Investor Meeting - Fireside Chat - M-Vest
2022-06-02 12:00 pm Annual General Meeting
2022-05-16 04:05 pm Q1 2022 Earnings Release
2022-03-31 06:04 pm FY 2021 Earnings Release
2022-02-23 12:30 pm Aegis Capital Virtual Summit
2022-01-27 04:15 pm Business Update Call
2021-11-10 08:00 am Q3 2021 Earnings Release
2021-09-26 Cantor Fitzgerald Global Healthcare Conference
2021-09-12 H.C. Wainwright Global Investment Conference
2021-08-12 09:00 am Interim 2021 Earnings Release
2021-06-02 Annual General Meeting
2021-05-11 04:01 pm Q1 2021 Earnings Release
2021-03-30 05:49 pm FY 2020 Earnings Release

Annual results

Fiscal PeriodDecember 2018 2019 2020 2021 2022 2023
Net sales
Million USD		Released
Forecast
Spread 		2,76
1,84
49.51%		1,02
1,89
-45.81%		1,00
1,50
-33.33%		1,54
2,43
-36.88%		3,09
2,19
40.91%
21,4

EBITDA
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		-28,7
-29,3
1.88%		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-24,1
-26,8
10.13%		-29,1
-30,6
4.92%		-22,4
-22,5
0.61%		-43,7
-40,8
-7.14%		-30,0
-30,7
2.19%
5,60

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-22,1
-24,5
9.92%		-29,7
-31,2
4.94%		-22,3
-22,5
0.53%		-43,2
-38,8
-11.27%		-30,4
-31,8
4.58%
4,30

Net income
Million USD		Released
Forecast
Spread 		-23,5
-25,9
9.3%		-29,7
-31,2
4.94%		-22,3
-22,5
0.53%		-47,3
-40,9
-15.79%		-30,4
-31,8
4.58%
4,30

EPS
USD		Released
Forecast
Spread 		-2,89
-5,51
47.48%		-3,51
-3,70
5.05%		-2,44
-2,44
0%		-3,85
-3,50
-10%		-1,62
-1,74
6.72%
0,07

Announcement Date28/03/1908/04/2030/03/2101/04/2222/05/23-

Quarterly results

Fiscal PeriodDecember 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,52
0,30
71.67%		0,57
1,90
-70%		1,19
1,00
18.7%		0,29
10,5
-97.21%		0,40
7,47
-94.66%		1,21
0,31
293.41%





0,42
1,50
-72.2%
0,30

EBIT
Million USD		Released
Forecast
Spread 		-21,0
-7,44
-182.47%		-9,97
-6,75
-47.69%		-7,42
-9,00
17.51%		-7,74
1,21
-738.1%		-7,41
-1,13
-558.84%		-7,42
-8,12
8.58%





-0,87
-4,20
79.31%
-1,00

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-21,0
-7,30
-187.7%		-10,2
-5,43
-88.52%		-7,77
-9,00
13.71%		-7,98
0,96
-928.99%		-8,24
-1,21
-581.85%		-10,5
-8,11
-29.36%





-0,08
-4,20
98.02%
-1,00

Net income
Million USD		Released
Forecast
Spread 		-24,1
-7,30
-230.73%		-13,4
-5,43
-146.41%		-7,77
-9,00
13.71%		-7,98
-0,39
-1959.1%		-8,24
-8,71
5.43%		-10,5
-8,11
-29.36%


12,1


-0,08
-4,20
98.02%
-1,00

EPS
USD		Released
Forecast
Spread 		-1,94
-0,50
-288%		-0,92
-0,33
-183.08%		-0,44
-0,51
13.73%		-0,45
-0,06
-650%		-0,47
-0,17
-176.47%		-0,50
-0,41
-21.95%		-0,22


0,33


0,00
-0,10
-
-0,02

Announcement Date10/11/2101/04/2216/05/2216/08/2221/11/2222/05/2309/06/2314/09/2303/11/23-

Upcoming sector events for Aridis Pharmaceuticals, Inc.

2024-04-28 HITGEN INC.: Q1 2024 Earnings Release (Projected)
2024-04-28 CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release (Projected)
2024-04-29 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-04-29 ARVINAS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-29 MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q1 2024 Earnings Release
2024-04-29 WUXI APPTEC CO., LTD.: Q1 2024 Earnings Release
2024-04-30 04:05 pm EXELIXIS, INC.: Q1 2024 Earnings Release
2024-04-30 SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release
2024-04-30 MACROGENICS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30 REGENXBIO INC.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for Aridis Pharmaceuticals, Inc.

Today INVENTISBIO CO., LIMITED: Q4 2023 Earnings Release
Today SHANGHAI MEDICILON INC.: Q1 2024 Earnings Release (Projected)
Today SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release (Projected)
Today DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
Today SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release
Today REMEGEN CO., LTD.: Q1 2024 Earnings Release
2024-04-25 06:30 am SAGE THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-24 JIANGSU YAHONG MEDITECH CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-24 BIO-THERA SOLUTIONS, LTD.: Q1 2024 Earnings Release (Projected)
2024-04-24 PTC THERAPEUTICS, INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ARDS Stock
  4. Calendar Aridis Pharmaceuticals, Inc.